A new device called Lenire is offering hope to the millions of Americans suffering from tinnitus, a condition characterized by a persistent high-pitched buzz or ring in the ears. More than 25 million adults in the U.S. are affected by tinnitus, which can be distressing and difficult to manage.
Lenire, recently approved by the FDA, uses electrical stimulation of the tongue to treat tinnitus. Musician Victoria Banks, who struggled with the condition for years, found relief using the device after other treatments failed. Clinical trials have shown promising results, with 84% of participants experiencing significant improvements in their condition after using Lenire for 12 weeks.
The device works by helping shift the brain’s focus away from the buzz, combining tongue stimulation with sound therapy. However, there is still uncertainty about how long the benefits last and the device’s durability.
Research also suggests that hearing aids can be effective in treating tinnitus, especially among older adults with hearing loss. Users like scientist Bruce Freeman have found relief using both hearing aids and the Lenire device, along with mindfulness practices like swimming.
While Lenire can be costly and is not covered by insurance, many participants in clinical trials would recommend it to others. More research is needed to fully understand the long-term effects of the device and its effectiveness in managing tinnitus. However, for now, Lenire offers a promising new option for those struggling with this debilitating condition.
